Literature DB >> 30467614

Aerobic vaginitis in late pregnancy and outcomes of pregnancy.

Cha Han1, Huiyang Li1, Lulu Han1, Chen Wang1, Ye Yan1, Wenhui Qi1, Aiping Fan1, Yingmei Wang1, Fengxia Xue2.   

Abstract

The purpose of this study was to investigate the risk factors and pregnancy outcomes for aerobic vaginitis (AV) in late pregnancy. A total of 624 pregnant women who were treated in the perinatal unit at Tianjin Medical University General Hospital and 365 nonpregnant women who were evaluated at a health management center from January 2015 to June 2016 were recruited for this case-control study. A questionnaire covering personal hygiene habits and sociodemographic factors was administered to pregnant women to analyze risk factors for AV. Bacterial vaginosis, AV, vulvovaginal candidiasis, and Trichomonas vaginitis were scored according to standardized definitions. Pregnancy outcomes were followed up and recorded. The chi-square test and univariate and multivariate logistic regression analyses were used for statistical evaluation. The prevalence of vaginal infection in pregnant and nonpregnant women were 27.9% and 15.3%, respectively (P < 0.05). AV was identified more frequently in pregnant women than in nonpregnant women (4.2% vs. 1.4%; P < 0.05). A history of vaginal infection within 1 year (odds ratio [OR] = 3.219, 95% confidence interval [CI] 1.103-9.346) and external hemorrhoids (OR = 11.233, 95% CI 4.647-27.155) were independent risk factors for AV during pregnancy. A higher incidence of premature rupture of membranes (PROM) was significantly associated with AV (P < 0.05). AV is common in late pregnancy. Clinicians should pay more attention to vaginal microbiota evaluations during pregnancy.

Entities:  

Keywords:  Aerobic vaginitis; Pregnancy; Preterm birth; Prevalence; Vaginal microbiota

Mesh:

Year:  2018        PMID: 30467614     DOI: 10.1007/s10096-018-3416-2

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  31 in total

Review 1.  Intrauterine infection and preterm delivery.

Authors:  R L Goldenberg; J C Hauth; W W Andrews
Journal:  N Engl J Med       Date:  2000-05-18       Impact factor: 91.245

Review 2.  Understanding the bacterial flora of the female genital tract.

Authors:  B Larsen; G R Monif
Journal:  Clin Infect Dis       Date:  2001-02-09       Impact factor: 9.079

Review 3.  Preterm delivery.

Authors:  Michael M Slattery; John J Morrison
Journal:  Lancet       Date:  2002-11-09       Impact factor: 79.321

4.  Topical kanamycin: an effective therapeutic option in aerobic vaginitis.

Authors:  G Tempera; G Abbadessa; G Bonfiglio; E Cammarata; A Cianci; S Corsello; A Raimondi; G Ettore; D Nicolosi; P M Furneri
Journal:  J Chemother       Date:  2006-08       Impact factor: 1.714

5.  Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis.

Authors:  Gilbert G G Donders; Annie Vereecken; Eugene Bosmans; Alfons Dekeersmaecker; Geert Salembier; Bernard Spitz
Journal:  BJOG       Date:  2002-01       Impact factor: 6.531

6.  Effect of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis: a randomised controlled trial.

Authors:  Austin Ugwumadu; Isaac Manyonda; Fiona Reid; Phillip Hay
Journal:  Lancet       Date:  2003-03-22       Impact factor: 79.321

7.  Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation.

Authors:  R P Nugent; M A Krohn; S L Hillier
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

8.  Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy.

Authors:  G G Donders; K Van Calsteren; G Bellen; R Reybrouck; T Van den Bosch; I Riphagen; S Van Lierde
Journal:  BJOG       Date:  2009-06-17       Impact factor: 6.531

9.  Microbiological/clinical characteristics and validation of topical therapy with kanamycin in aerobic vaginitis: a pilot study.

Authors:  G Tempera; G Bonfiglio; E Cammarata; S Corsello; A Cianci
Journal:  Int J Antimicrob Agents       Date:  2004-07       Impact factor: 5.283

10.  Intravaginal clindamycin to reduce preterm birth in women with abnormal genital tract flora.

Authors:  Ronald F Lamont; Sheila L B Duncan; Debashis Mandal; Paul Bassett
Journal:  Obstet Gynecol       Date:  2003-03       Impact factor: 7.661

View more
  16 in total

1.  Prevalence of bacterial vaginosis and aerobic vaginitis and their associated risk factors among pregnant women from northern Ethiopia: A cross-sectional study.

Authors:  Gebrehiwet Tesfay Yalew; Saravanan Muthupandian; Kiflom Hagos; Letemichael Negash; Gopinath Venkatraman; Yemane Mengsteab Hagos; Hadush Negash Meles; Hagos Haileslasie Weldehaweriat; Hussein O M Al-Dahmoshi; Morteza Saki
Journal:  PLoS One       Date:  2022-02-25       Impact factor: 3.240

2.  A prediction nomogram for neonatal acute respiratory distress syndrome in late-preterm infants and full-term infants: A retrospective study.

Authors:  Hui Liu; Jing Li; Jingyu Guo; Yuan Shi; Li Wang
Journal:  EClinicalMedicine       Date:  2022-06-25

3.  Effect of bacterial vaginosis on preterm birth: a meta-analysis.

Authors:  Trishna Mohanty; Prakash Prabhakarrao Doke; Sana Rafiq Khuroo
Journal:  Arch Gynecol Obstet       Date:  2022-10-17       Impact factor: 2.493

Review 4.  The Role of Microbiota in Infant Health: From Early Life to Adulthood.

Authors:  Yao Yao; Xiaoyu Cai; Yiqing Ye; Fengmei Wang; Fengying Chen; Caihong Zheng
Journal:  Front Immunol       Date:  2021-10-07       Impact factor: 7.561

5.  The Vaginal Community State Types Microbiome-Immune Network as Key Factor for Bacterial Vaginosis and Aerobic Vaginitis.

Authors:  Francesco De Seta; Giuseppina Campisciano; Nunzia Zanotta; Giuseppe Ricci; Manola Comar
Journal:  Front Microbiol       Date:  2019-10-30       Impact factor: 5.640

Review 6.  The Interaction Between Microorganisms, Metabolites, and Immune System in the Female Genital Tract Microenvironment.

Authors:  Huanrong Li; Yuqin Zang; Chen Wang; Huiyang Li; Aiping Fan; Cha Han; Fengxia Xue
Journal:  Front Cell Infect Microbiol       Date:  2020-12-23       Impact factor: 5.293

Review 7.  The pathogenesis of prevalent aerobic bacteria in aerobic vaginitis and adverse pregnancy outcomes: a narrative review.

Authors:  Xiaotong Ma; Ming Wu; Chen Wang; Huiyang Li; Aiping Fan; Yingmei Wang; Cha Han; Fengxia Xue
Journal:  Reprod Health       Date:  2022-01-28       Impact factor: 3.223

8.  Characterization of aerobic vaginitis in late pregnancy in a Chinese population: A STROBE-compliant study.

Authors:  Yuanting Tang; Fan Yu; Zhengqiang Hu; Luyun Peng; Yongmei Jiang
Journal:  Medicine (Baltimore)       Date:  2020-06-19       Impact factor: 1.817

9.  Does Aerobic Vaginitis Have Adverse Pregnancy Outcomes? Prospective Observational Study.

Authors:  Mahmoud F Hassan; Nancy M A Rund; Osama El-Tohamy; Mahmoud Moussa; Yahia Z Ali; Nehal Moussa; Ahmed A Abdelrazik; Enas A A Abdallah
Journal:  Infect Dis Obstet Gynecol       Date:  2020-01-18

10.  The Pathogenesis Of Streptococcus anginosus In Aerobic Vaginitis.

Authors:  Zhi Tao; Lei Zhang; Qiongqiong Zhang; Tao Lv; Rui Chen; Lijun Wang; Zhenyu Huang; Long Hu; Qinping Liao
Journal:  Infect Drug Resist       Date:  2019-12-04       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.